Increased Nuclear Expression of Growth Hormone Receptor in Uterine Cervical Neoplasms of Women under 40 Years Old
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-10-01
著者
-
NAKAYAMA Hiroki
Department of Gynecology, Kanagawa Cancer center
-
Okamoto Naoyuki
Division Of Cancer Prevention & Cancer Control Kanagawa Cancer Center Research Institute
-
DEHARI REIKO
Department of Surgical Pathology, Kanagawa Cancer Center Hospital
-
NAKAMURA YOSHIYASU
Division of Molecular Pathology & Genetics, Kanagawa Cancer Center Research Institute
-
Nakayama Hiroki
Department Of Gynecology Kanagawa Cancer Center
-
Nakamura Yoshiyasu
Division Of Molecular Pathology & Genetics Kanagawa Cancer Center Research Institute
-
Dehari Reiko
Department Of Surgical Pathology Kanagawa Cancer Center Hospital
-
Nakayama Hiroki
Department Of Gynecology Kanagawa Cancer Center Hospital
-
Nakayama Hiroki
Department Of Clinical Molecular Biology Faculty Of Medicine Kyoto University
-
DEHARI REIKO
Department of Internal Medicine, Tokyo University School of Medicine
関連論文
- Down-regulation of members of glycolipid-enriched membrane raft gene family, MAL and BENE, in cervical squamous cell cancers
- Analysis of stage IVB endometrial carcinoma patients with distant metastasis : a review of prognoses in 55 patients
- Change of cyclin D2 mRNA expression during murine testis development detected by fragmented cDNA subtraction method
- Historical control study of paclitaxel-carboplatin (TJ) versus conventional platinum-based chemotherapy (CAP) for epithelial ovarian cancer
- Positive endometrial cytology associated with primary gastric adenocarcinomas: clinical and cytopathologic findings in 16 patients
- Anxiety and prevalence of psychiatric disorders among patients awaiting surgery for suspected ovarian cancer
- Increased Nuclear Expression of Growth Hormone Receptor in Uterine Cervical Neoplasms of Women under 40 Years Old
- Endometrial adenocarcinoma without myometrial invasion metastasizing to the pancreas and masquerading as primary pancreatic neoplasm
- IS-11 Prognostic factors for recurrence in patients with FIGO stage I, II and III endometrioid endometrial cancer(Group2 Oncology2,International Session)
- Infrequent APC Mutations in Serrated Adenoma
- ISP-5-1 Long term results of a phase II study of paclitaxel and carboplatin with a biweekly schedule in patients with epithelial ovarian cancer(Group 5 Oncology 5,IS Poster,International Session)